22 . May , 2019 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Fludarabine Phosphate

Big Image Pronouncation: (flew-DAR-uh-BEAN)
Class: Purine antimetabolite

Trade Names:
- Powder for injection 50 mg

Mechanism of Action


Fludarabine is a fluorinated nucleotide analog of the antiviral agent vidarabine. Fludarabine's metabolite appears to act by inhibiting DNA polymerase alpha, ribonucleotide reductase, and DNA primase, thus inhibiting DNA synthesis.



Fludarabine is rapidly converted to the active metabolite, 2‐fluoro‐ara‐A, within minutes after IV infusion.


In vitro, plasma protein binding of fludarabine ranged between 19% and 29%.


The t ½ of 2‐fluoro‐ara‐A is approximately 20 h.


Renal Cl represents approximately 40% of the total body Cl.

Indications and Usage

Refractory or progressive chronic B-cell lymphocytic leukemia.

Unlabeled Uses

Leukemias, non-Hodgkin lymphoma.


Standard considerations.

Dosage and Administration

Chronic Lymphocytic Leukemia

IV 25/m 2 /day over approximately 30 min daily for 5 consecutive days. Each 5‐day course should commence every 28 days.

Renal Function Impairment

IV Reduce dose 20% in moderate renal function impairment (CrCl 30 to 70 mL/min/1.73 m 2 ). Do not administer in patients with severely impaired renal function (CrCl less than 30 mL/min/1.73 m 2 ).

Drug Interactions


Concomitant therapy may cause severe or fatal pulmonary toxicity.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Deep venous thrombosis, phlebitis (at least 1%); aneurysm; angina; arrhythmia; cerebrovascular accident; CHF; MI; supraventricular tachycardia; transient ischemic attack.


Weakness (65%); fatigue (38%); paresthesia (12%); malaise (8%); agitation; coma; confusion; headache; weakness.


Rash (15%); diaphoresis (13%); pruritus (at least 1%); alopecia; seborrhea.


Visual disturbances (15%); hearing loss, sleep disorder (at least 1%); cerebellar syndrome; depression; impaired mentation.


Nausea/vomiting (36%); anorexia (34%); diarrhea (15%); GI bleeding (13%); constipation (at least 1%); dysphagia; esophagitis; mucositis; stomatitis.


Dysuria, hematuria; urinary infection (at least 1%); abnormal renal function test; hemorrhagic cystitis; proteinuria; renal failure; urinary hesitancy.


Anemia (60%); neutropenia (59%); thrombocytopenia (55%); autoimmune hemolytic anemia; pancytopenia (postmarketing).


Abnormal LFTs (at least 1%); cholelithiasis; liver failure.




Hyperglycemia (at least 1%); tumor lysis syndrome (including hyperuricemia, hyperphosphatemia, hypocalcemia, metabolic acidosis, hyperkalemia, hematuria, urate crystalluria, renal failure).


Myalgia (16%); arthralgia; osteoporosis.


Cough (44%); dyspnea, pneumonia (22%); hemoptysis, upper respiratory tract infections (at least 1%); allergic pneumonitis; bronchitis; epistaxis; hypoxia; pharyngitis; pulmonary hypersensitivity; sinusitis; respiratory distress, pulmonary hemorrhage, pulmonary fibrosis, respiratory failure (postmarketing).


Fever (69%); infection (44%); pain (22%); chills, edema (19%); dehydration; hemorrhage.



Neurotoxicity associated with high doses in dose ranging studies in acute leukemia. Autoimmune hemolytic anemia reported after at least 1 cycle. Concurrent use with pentostatin not recommended, based on increased incidence of fatal pulmonary toxicity. Severe CNS toxicity occurred in 36% patients receiving doses approximately 4 times greater than the recommended dose. (96 mg/m 2 /day for 5 to 7 days). At recommended doses, severe CNS toxicity is rare.

Bone marrow suppression

Severe bone marrow suppression, notably anemia, thrombocytopenia, and neutropenia, occurred.


Category D .




Safety and efficacy not established.

Renal Function

Administer cautiously.

Dose-dependent toxicity

There are clear dose-dependent toxic effects seen with fludarabine.


Transfusion-associated graft/host disease may occur after transfusion of non-irradiated blood.

Tumor lysis syndrome

Tumor lysis syndrome has occurred.



Irreversible CNS toxicity characterized by delayed blindness, coma, and death; severe thrombocytopenia and neutropenia.

Patient Information

  • Review the treatment regimen including dosing schedule, duration of treatment, and monitoring that will be required.
  • Advise patient, family, or caregiver that medication will be prepared and administered by health care providers in a health care setting.
  • Advise patient, family, or caregiver that medication may be used in combination with other agents to achieve maximum benefit possible.
  • Advise patient, family, or caregiver to immediately report any of the following to health care provider: rash; hives; difficulty breathing; fever, chills, or other signs of infection; bleeding or unusual bruising; sores in mouth; dark urine; yellowing of skin or eyes; pain, redness, or swelling at injection site.
  • Advise patient, family, or caregiver to report any of the following to health care provider: persistent nausea, vomiting, diarrhea, or appetite loss; persistent or worsening general body weakness.
  • Caution women of childbearing potential to avoid becoming pregnant during therapy.

Recent Drug Updates at DrugIndexOnline:

Acyclovir Suspension Acyclovir Suspension
Generic Name: Acyclovir Suspension (A-SIKE-low-vir) Brand Name: ZoviraxAcyclovir Suspension is used for:Treating shingles or chickenpox, or treating or suppressing genital herpes. It may also be used for other conditions as determined by your doctor. Acyclovir Suspension is an antiviral. It work more...

captopril captopril
Generic Name: captopril (KAP toe pril) Brand Names: Capoten What is captopril? Captopril is in a group of drugs called ACE inhibitors. ACE stands for angiotensin converting enzyme. Captopril is used to treat high blood pressure (hypertension), congestive heart failure, kidney problems c more...

Factive Factive
Generic Name: Gemifloxacin (je-mi-FLOX-a-sin) Brand Name: FactiveFactive is used for:Treating infections caused by certain bacteria. Factive is a fluoroquinolone antibiotic. It works by killing sensitive bacteria. Do NOT use Factive if: you are allergic to any ingredient in Factive or to oth more...

Halothane Halothane
Some commonly used brand names are: In the U.S.— Amidate 2 Brevital 6 Diprivan 9 Ethrane 1 Fluothane 3 Forane 4 Ketalar 5 Penthrane 7 Pentothal 10 In Canada— Brietal 6 Diprivan 9 Ethrane 1 Fluothane 3 Forane 4 Ketalar 5 Pentothal 10 Other commonly used names are: Methohexitone an more...

Maxair Maxair
Generic Name: pirbuterol acetate Dosage Form: Inhalation aerosol For Oral Inhalation Only Maxair Description The active component of Maxair Inhaler (pirbuterol acetate) is (R,S)a6-{ [(1,1-dimethylethyl)amino]methyl}-3-hydroxy-2,6-pyridine-dimethanol monoacetate salt, a beta-2 adrenergic broncho more...

Priscoline Priscoline
Generic Name: tolazoline hydrochloride Dosage Form: Injection C98-24665480       Priscoline® hydrochloride       tolazoline hydrochloride injection, USP       Ampuls       Rx only  &n more...

Pro-Fast SA Pro-Fast SA
Generic Name: Phentermine Capsules and Tablets (FEN-ter-meen) Brand Name: Examples include Adipex P and Pro-Fast SAPro-Fast SA is used for:Reducing weight in obese patients when used short-term and combined with exercise, diet, and behavioral modification. Pro-Fast SA is an appetite suppressa more...

Propranolol Hydrochloride/Hydrochlorothiazide (HCTZ) Propranolol Hydrochloride/Hydrochlorothiazide (HCTZ)
Pronouncation: (pro-PRAN-oh-lahl HIGH-droe-KLOR-ide/high-droe-klor-THIGH-uh-zide) Class: Antihypertensive combination Trade Names: Inderide - Tablets 40 mg propranolol/25 mg hydrochlorothiazide Trade Names: Propranolol Hydrochloride/Hydrochlorothiazide - Tablets 80 mg propranolol/25 mg hydrochlorot more...